Jason Lief, Partner, Windels Marx Lane & Mittendorf, LLP to Speak at The Knowledge Group’s Biotech and Pharmaceutical Patent Law

Top Quote The Knowledge Group, the leading producer of regulatory-focused webcasts, has announced today that Jason Lief, Partner, Windels Marx Lane & Mittendorf, LLP will speak at its webcast entitled, “Biotech and Pharmaceutical Patent Law: Cutting-Edge Issues to Watch For.” End Quote
  • (1888PressRelease) September 16, 2022 - This event is scheduled for September 16, 2022 from 12:00 PM to 1:30 PM ET.

    For further details, please visit: https://knowledgewebcasts.com/know-portfolio/biotech-and-pharmaceutical-patent-law-cle/

    About Jason Lief
    Jason Lief is a premier patent trial lawyer with 25 years of experience. He has litigated and tried dozens of major patent and other intellectual property cases on behalf of some of the world’s most innovative and dynamic companies, often involving billion-dollar products. Applying his legal and scientific training, Jason has established a reputation for winning outcomes and courtroom excellence.

    Jason’s cases include major Hatch-Waxman pharmaceutical litigations (Zantac®, Wellbutrin®, Wellbutrin SR®, Wellbutrin XL®, Ceftin®, Intuniv®, Vyvanse®, Oxtellar XR®, Angiomax®, and Lialda®), as well as biotech, chemical, and consumer product patent cases. Jason has also litigated trade secret, trademark, copyright, and IP contract disputes. He has argued before the U.S. Court of Appeals for the Federal Circuit and appeared in foreign courts pursuant to the Hague Convention. Jason has also successfully litigated in the inter-partes review (IPR) arena.

    About Windels Marx Lane & Mittendorf, LLP
    Windels Marx is a full-service law firm headquartered in New York City, with offices in New Brunswick and Madison, New Jersey, and Stamford, Connecticut. The Firm has nearly 150 lawyers and provides services in excess of 20 practice areas, the largest of which by volume of business are financial transactions, real estate, litigation, and bankruptcy. The Firm serves a myriad of domestic and foreign clients, including banks and finance companies, insurance companies, manufacturers, non-profit entities, and government-sponsored enterprises.

    Event Summary
    Several court cases continue to shape the biotech and pharmaceutical patent litigation in the United States and Canada.

    In the United States, Amgen Inc. v. Sanofi-Aventis (2021) has revived the discussion on the enablement of genus claims in biotechnology inventions. Moreover, the multiple filings for abbreviated new drug applications (ANDA) also raise concerns, particularly in cases that may provoke multidistrict litigation. These and other developments further expand the patent litigation landscape, introducing new regulations that practitioners must be aware of to avoid legal pitfalls.

    In Canada, summary trials are increasingly affecting the way litigation is proceeding. Issues concerning cases that impact the scope of the Notice of Allegation, certificates of supplementary protection, and the Patent Medicines Price Review Board, as well as those relating to claim construction, obviousness, and patentable subject matter, must be considered.

    Join a panel of key thought leaders and distinguished professionals organized by The Knowledge Group as they provide a comprehensive discussion of the recent litigation trends in the biotech and pharmaceutical industry. Speakers, among other things, will also offer practical tips and strategies in this ever-changing regulatory landscape.

    Key Topics include:
    • Recent Litigation Trends and Developments in the Biotech and Pharmaceutical Industry
    • Enablement of Genus Claims for Biotechnology Inventions
    • Multiple Filing of Abbreviated New Drug Applications (ANDA): Implications
    • Recent and Notable Court Cases
    • What Lies Ahead

    About The Knowledge Group
    Founded in November 2006, The Knowledge Group has been at the forefront of providing quality continuing education programs for lawyers, accountants, financial executives, risk and compliance specialists, human resources professionals, technology officers, and business consultants in a wide range of industries.

    The Knowledge Group strives to be the best-in-class provider of continuing education by bringing forth relevant content you can’t get anywhere else.

  • FB Icon Twitter Icon In-Icon
Contact Information